Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway
Notably, H.p can transiently survive in saliva, and its survival ability is significantly enhanced in the presence of S.m and Actinomyces naeslundii (Scholz et al., 2025), providing a possibility for transmission from the oral cavity to the stomach
Important formulation note: Avoid Disodium EDTA and strong chelating agents in the same formula, because they can bind copper and reduce the performance of the copper peptide complex
Comparison prices to brand-name GLP-1 medications (which can run $900-$1,300+ per month without insurance) are the brand's own reference points and may not reflect prevailing market prices in all circumstances
Reduced-Frequency GLP1 Therapy Maintains Weight, Body Composition, and Metabolic Syndrome Improvements: A Case Series